Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Bayer AG

Start price
Target price
Perf. (%)
€40.83
15.11.23
€35.00
15.11.24
-19.02%
22.11.23

Probably not worthwhile Investment
Higher risks for its business
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€239.95
01.04.22
€330.00
18.12.23
41.68%
14.11.23

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€337.60
09.04.23
€362.00
09.10.23
57.73%
09.10.23

buy
Amgen Inc.

Start price
Target price
Perf. (%)
€246.80
19.09.23
€250.00
19.09.24
4.13%
27.09.23

Could be worthwhile Investment >10% per year
High dividend yield expected
positive Cash Flow expected
Good rating
buy
AstraZeneca plc

Start price
Target price
Perf. (%)
€116.40
20.09.22
€125.00
20.09.23
8.29%
21.09.23

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€502.50
17.08.23
€510.00
17.08.24
10.75%
13.09.23

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Baxter International

Start price
Target price
Perf. (%)
€59.15
25.08.22
€50.00
25.08.23
-35.42%
26.08.23

buy
Novartis AG ADR

Start price
Target price
Perf. (%)
€84.20
25.08.22
€88.00
25.08.23
11.88%
26.08.23

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€152.60
24.07.23
€155.00
24.07.24
3.47%
16.08.23

High dividend yield expected
positive Cash Flow expected
Good rating
Standard Investments for future growth
buy
Novo Nordisk A/S

Start price
Target price
Perf. (%)
€100.76
08.08.22
€120.00
08.08.23
69.31%
09.08.23

buy
Bayer AG

Start price
Target price
Perf. (%)
€50.71
30.06.23
€52.00
30.06.24
3.31%
07.08.23

Sustainability is little important
high free float
Higher risks for its business
Below average Marketposition
buy
Align Technology

Start price
Target price
Perf. (%)
€282.75
03.08.22
€300.00
03.08.23
19.54%
04.08.23

buy
EssilorLuxottica SA

Start price
Target price
Perf. (%)
€146.15
15.07.22
€175.00
15.07.23
21.16%
16.07.23

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€388.00
05.05.23
€395.00
05.05.24
3.52%
12.05.23

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
buy
Seagen Inc.

Start price
Target price
Perf. (%)
€165.90
15.08.22
€180.00
31.01.24
9.64%
08.05.23

Could be very worthwhile Investment >20% year
Pfizer Inc.

Start price
Target price
Perf. (%)
€47.16
03.05.22
€40.00
03.05.23
-26.10%
04.05.23

buy
Intuitive Surgical Inc

Start price
Target price
Perf. (%)
€233.45
25.04.22
€250.00
25.04.23
14.61%
26.04.23

Could be worthwhile Investment >10% per year
Fair valuation
Some uniques
Higher risks for its business
Merck KGaA

Start price
Target price
Perf. (%)
€190.20
23.01.23
€175.00
23.04.23
-12.41%
23.04.23

Some uniques
Future proof or reliable business model
overvalued
Low dividend yield expected
buy
Sarepta Therapeutics

Start price
Target price
Perf. (%)
€76.43
02.04.22
€90.00
02.04.23
67.74%
03.04.23

buy
Seagen Inc.

Start price
Target price
Perf. (%)
€152.08
07.09.22
€180.00
31.12.24
21.00%
21.03.23

Could be very worthwhile Investment >20% year
buy
Novo Nordisk A/S ADR

Start price
Target price
Perf. (%)
€92.20
28.02.22
€110.00
28.02.23
46.96%
28.02.23

buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€407.05
24.01.22
€418.00
24.01.23
10.66%
25.01.23

Could be worthwhile Investment >10% per year
buy
Medtronic plc

Start price
Target price
Perf. (%)
€72.49
18.12.22
€75.00
18.12.23
5.39%
04.01.23

buy
Novo Nordisk A/S

Start price
Target price
Perf. (%)
€86.20
20.01.22
€125.00
20.01.23
47.29%
02.01.23

buy
Biogen Inc.

Start price
Target price
Perf. (%)
€208.25
27.12.21
€215.00
27.12.22
23.82%
28.12.22

Could be worthwhile Investment >10% per year